Cellular Dynamics International

Cellular Dynamics International

Develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

Valuation: €0.0

round

$307m

Valuation: $307m

Acquisition
Total Funding000k
More about Cellular Dynamics International
Made with AI
Edit

Fujifilm Cellular Dynamics, a subsidiary of Fujifilm, specializes in the development and manufacturing of induced pluripotent stem cells (iPSCs) for various applications including drug discovery, safety pharmacology, and regenerative medicine. The company serves pharmaceutical companies, research institutions, and biotech firms by providing high-quality iPSC-derived cells such as cardiomyocytes, neurons, and other specialized cell types. Operating in the biotechnology and life sciences market, Fujifilm Cellular Dynamics leverages its proprietary episomal reprogramming technology to produce iPSCs at an industrial scale. The business model revolves around the sale of iCell products, custom cell development services, and collaborative research agreements. Revenue is generated through product sales, service contracts, and strategic partnerships aimed at advancing therapeutic approaches and drug discovery solutions.

Keywords: iPSCs, drug discovery, regenerative medicine, cardiomyocytes, neurons, biotechnology, life sciences, cell manufacturing, therapeutic approaches, safety pharmacology.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Cellular Dynamics International

Edit